Valuation: Indivior PLC

Market Cap 4.19B 3.66B 3.44B 3.14B 5.9B 401B 5.9B 41.33B 15.95B 205B 15.75B 15.4B 660B P/E 2026 *
9.55x
P/E 2027 * 8.66x
Enterprise Value 4.18B 3.65B 3.43B 3.13B 5.88B 400B 5.88B 41.21B 15.9B 204B 15.7B 15.36B 658B EV / Sales 2026 *
3.14x
EV / Sales 2027 * 2.59x
Free-Float
98.18%
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-1.82%-1.64% - - 4.19B
+0.45%+3.00%+55.00%+112.54% 1,038B
-0.10%+0.74%+54.52%+67.72% 649B
+0.28%+0.82%+19.15%+73.63% 467B
-0.19%+0.75%+37.34%+45.03% 355B
+0.28%+2.23%+19.12%+25.62% 269B
+0.89%+4.26%+12.10%+16.41% 260B
+4.34%+9.21%+43.44%+53.25% 213B
-0.46%-7.70%-33.40%-59.71% 176B
+1.40%+4.35%+35.72%+103.53% 187B
Average +0.44%+1.04%+27.00%+48.67% 401.68B
Weighted average by Cap. +0.58%+1.47%+36.79%+67.08%

Financials

2026 *2027 *
Net sales 1.33B 1.16B 1.09B 998M 1.87B 127B 1.87B 13.13B 5.07B 65.03B 5B 4.89B 210B 1.4B 1.22B 1.15B 1.05B 1.97B 134B 1.97B 13.8B 5.32B 68.32B 5.26B 5.14B 220B
Net income 474M 414M 390M 355M 667M 45.34B 667M 4.68B 1.8B 23.15B 1.78B 1.74B 74.64B 530M 463M 435M 397M 746M 50.66B 746M 5.22B 2.02B 25.87B 1.99B 1.95B 83.41B
Net Debt -12.5M -10.92M -10.27M -9.37M -17.58M -1.19B -17.59M -123M -47.55M -610M -46.94M -45.91M -1.97B -570M -498M -468M -427M -802M -54.49B -802M -5.62B -2.17B -27.83B -2.14B -2.09B -89.71B
Logo Indivior PLC
Indivior Pharmaceuticals, Inc. is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. It sells its products in the United States and in other selected areas of the world.
Employees
833
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!